Andrew Robbins
→ Rife with turmoil and hit with a barrage of FDA holds as it spiraled into penny-stock territory, Unum Therapeutics hopes a new name — Cogent Biosciences — and a new CEO can turn its fortunes around. Andrew Robbins takes control now and… […]
Atea Pharmaceuticals and SQZ Biotechnologies have priced their public debuts, adding to this year’s record biotech IPO raise — a pot spilling over $13 billion that dwarfs the total raises of the last four years.
Last Friday, Nasdaq head of healthcare l… […]
WESTLAKE VILLAGE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological di… […]
SANTA MONICA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced it has entered into an agreement with drug delivery specialist Aptar Pharma (“Aptar”), for the development of OPNT003 nasal… […]
ANAHEIM, Calif.–(BUSINESS WIRE)– #AHigherStandard–NTS, the leader in testing, inspection, and certification solutions in North America, is pleased to announce that its laboratory in Huntsville, AL has expanded its testing capabilities with a multi-m… […]
IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel … […]
RANCHO SANTA MARGARITA, Calif.–(BUSINESS WIRE)–Applied Medical launches the next advancement of its Voyant Intelligent Energy system – a new algorithm to further enhance clinical performance. […]
The post VOTE! Election information for Bruins appeared first on Life Sciences.
[…]
SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter… […]
LOS ANGELES & RALEIGH, N.C.–(BUSINESS WIRE)– #H2S–Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart™ that provides a more complete fermented gas profile of a patient’s microbiome by meas… […]
Copyright © 2021 Biotech Networks, LLC
